Suven Pharmaceuticals Limited (SUVENPHAR) — Financial Flexibility Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Financial Flexibility Index of 0.33x as of December 2023. Free cash flow of Rs255.04 Million (operating CF Rs255.04 Million minus capex Rs0.00) represents 0% of total liabilities (Rs765.00 Million). Check cash flow reinvestment rate of Suven Pharmaceuticals Limited to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Suven Pharmaceuticals Limited Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Suven Pharmaceuticals Limited across 7 annual periods. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited cash conversion from operations.
Annual Financial Flexibility Index for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year free cash flow to debt coverage for Suven Pharmaceuticals Limited. Explore how well can Suven Pharmaceuticals Limited service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | Rs4.44 Billion | Rs2.88 Billion | Rs11.91 Billion | ▼ -81.5% |
| 2024 | 2.02x | Rs4.10 Billion | Rs3.58 Billion | Rs2.03 Billion | ▼ -36.9% |
| 2023 | 3.20x | Rs7.37 Billion | Rs4.51 Billion | Rs2.31 Billion | ▲ +138.5% |
| 2022 | 1.34x | Rs4.05 Billion | Rs3.30 Billion | Rs3.02 Billion | ▼ -20.4% |
| 2021 | 1.68x | Rs4.94 Billion | Rs3.83 Billion | Rs2.94 Billion | ▲ +7.1% |
| 2020 | 1.57x | Rs5.15 Billion | Rs4.16 Billion | Rs3.28 Billion | ▲ +182.5% |
| 2019 | 0.56x | Rs1.07 Billion | Rs504.05 Million | Rs1.93 Billion | — |